Vanessa Currat

Investor

Chief Legal Officer, Legal Affairs, Intellectual Property & Pre-Commercial Alliances at Debiopharm Innovation Fund

About

Chief Legal Officer overseeing Intellectual Property, Legal Affairs and Pre-Commercial Alliances. She joined Debiopharm in 1996 and holds law degrees from Paris universities, with expertise in IP, licensing and acquisitions.

Colleagues at Debiopharm Innovation Fund

Angela Zubel

Chief Development Officer, Research & Development at Debiopharm Innovation Fund

Bertrand Ducrey

Chief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm at Debiopharm Innovation Fund

Cedric Odje

Investment Associate at Debiopharm Innovation Fund

Chris Thomas

Director, Investments at Wollemi Capital

David Shin

Investor at Dash Fund

Dawid Książczak

Chief Legal Officer at McWin Capital Partners

Frédéric Lévy

Chief Scientific Officer, Search & Evaluation and Scientific Innovation at Debiopharm Innovation Fund

Kavita Patel

Principal at Muus Climate Partners

Frequently asked questions

Who is Vanessa Currat?: Chief Legal Officer overseeing Intellectual Property, Legal Affairs and Pre-Commercial Alliances. She joined Debiopharm in 1996 and holds law degrees from Paris universities, with expertise in IP, licensing and acquisitions.
Where does Vanessa Currat work?: Vanessa Currat is Chief Legal Officer, Legal Affairs, Intellectual Property & Pre-Commercial Alliances at Debiopharm Innovation Fund.